Contact Us

Prempro
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?









If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:



Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Woman wins $3 million verdict in case over Prempro link to cancer

Feb 20, 2007 | AP

Jennie Nelson, 67, of Dayton, was diagnosed with breast cancer in 2001 after taking Prempro for five years to treat symptoms of menopause. Her lawyers said Wyeth knew for decades the drug could cause breast cancer, but failed to warn patients.

More than 5,000 women have sued New Jersey-based Wyeth over its hormone drugs Premarin and Prempro. Wyeth has won two cases and lost two cases, which have been heard in Arkansas and Philadelphia.

Both drugs remain on the market and carry the approval of the U.S. Food and Drug Administration, and both continue to be prescribed annually to hundreds of thousands of menopausal women.

But the lawsuits pending against Wyeth accuse the company of minimizing the drugs' risks.

Wyeth said it would appeal Tuesday's ruling. It maintains that it is impossible to prove that Prempro caused individual cancer cases.

"We respectfully disagree that there is any scientific basis to support the jury's finding of a causal link between Wyeth's hormone therapies and the plaintiff's breast cancer," Wyeth's attorney, Barbara R. Binis, said in a statement.

Nelson originally won a $1.5 million jury award in the fall, but a judge declared a mistrial. The second trial began Jan. 11.

"The jurors in this case understood how important it was to evaluate all of the evidence, and to let Wyeth know that dangerous products need adequate warnings," Nelson's lawyer, said in a statement.


Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo